Imaging Agent of Alzheimer's Disease, Chronic Traumatic Encephalopathy and Other Neurodegenerative Diseases
CereMark Pharma to Commence Phase 3 FDA Clinical Study
Source: einnews.com
Ceremark Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ceremark Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ceremark Pharma Today - Breaking & Trending Today
Patent Award Notice: PET Scan Imaging Agent Detects both Tau Aggregates and Beta Amyloid Plaque Simultaneously
Share this article Share this article LEXINGTON, Ky., April 30, 2021 /PRNewswire/ -- CereMark Pharma, LLC (CereMark) has been notified by the University of California Los Angeles (UCLA) that a U.S. patent is awarded to UCLA for Flornaptitril, a PET scan imaging radiopharmaceutical which is licensed exclusively to CereMark. Flornaptitril binds with both tau aggregates and beta amyloid plaque to enhance PET scan imaging of these pathological proteins in the brain. CereMark clinical studies show that Flornaptitril binds with both tau aggregates and beta amyloid plaque in the brain to enhance PET...
Source: prnewswire.com